Interleukin-1 Receptor Antagonist Gene VNTR Polymorphism is Associated with Coronary Artery Disease

被引:0
|
作者
Arman, Ahmet
Soylu, Ozer
Yildirim, Ahmet
Furman, Andrzej
Ercelen, Nesrin
Aydogan, Hakki
Coker, Ajda
Tezel, Tuna
机构
[1] Marmara Univ, Hosp Dr Siyami Ersek, Fac Engn, Dept Cardiol, TR-34722 Istanbul, Turkey
[2] Bogazici Univ, Inst Ciencias Ambientais, Istanbul, Turkey
[3] Hosp Americano, Dept Genet Med, Istanbul, Turkey
[4] Artes & Ciencias Univ Marmara, Dept Biol, Istanbul, Turkey
关键词
Interleukin; 1; mini-satellite repeats; coronary arteriosclerosis; population; Turkey; /; epidemiology;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Coronary Artery Disease (CAD) is the atherosclerosis of coronary arteries that carry blood to the heart muscle. Atherosclerosis is an inflammatory disease. Cytokine gene variations such as those associated with the IL1 family are involved in the pathogenesis of atherosclerosis. Objective: The purpose of this study was to determine the relationship between IL1 family polymorphisms (IL1RN VNTR, IL1B positions -511 and +3953) and CAD in Turkish population. Methods: 427 individuals were submitted to coronary angiography and were grouped as 170 control subjects and 257 CAD patients. The CAD subjects were divided into two subgroups: 91 Single Vessel Disease (SVD) and 166 Multiple Vessel Disease (MVD) subjects. The genotypes of IL1RN and of IL1B (-511, +3953) were determined by polymerase chain reaction (PCR) followed by restriction digestion analysis. Results: No significant difference was found in IL1RN and IL1B (-511 and +3953) genotype distributions between CAD and control subjects or MVD and control subjects. However, significant association was seen in IL1RN 2/2 genotype between SVD and control subjects (P = 0.016, x2: 10.289, OR: 2.94, 95% CI: 1.183-7.229). Similarly, no statistically significant difference was found in IL1RN and IL1B (-511 and +3953) allele frequencies between CAD and control subjects, MVD and control subjects or SVD and control subjects. Conclusion: No association was found in either allele frequency or genotype distribution of IL1RN and IL1B polymorphisms between CAD and the control groups. However; IL1RN 2/2 genotype may be a risk factor for SVD in the Turkish population. (Arq Bras Cardiol 2008; 91(5) : 268-273)
引用
收藏
页码:268 / 273
页数:6
相关论文
共 50 条
  • [21] SEVERITY OF ALOPECIA-AREATA IS ASSOCIATED WITH A POLYMORPHISM IN THE INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE
    TARLOW, JK
    CLAY, FE
    CORK, MJ
    BLAKEMORE, AIF
    MCDONAGH, AJG
    MESSENGER, AG
    DUFF, GW
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 103 (03) : 387 - 390
  • [22] Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene
    Papiol, S
    Molina, V
    Desco, M
    Rosa, A
    Reig, S
    Gispert, JD
    Sanz, J
    Palomo, T
    Fañanás, L
    NEUROIMAGE, 2005, 27 (04) : 1002 - 1006
  • [23] Investigating the relationship between the VNTR variant of the interleukin-1 receptor antagonist gene and coronary in-stent restenosis
    Klashami, Zeynab Nickhah
    Mostafavi, Atoosa
    Roudbordeh, Majid Gholamzadeh
    Abbasi, Ali
    Ebrahimi, Pirooz
    Asadi, Mojgan
    Amoli, Mahsa M.
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (10) : 8575 - 8587
  • [24] Investigating the relationship between the VNTR variant of the interleukin-1 receptor antagonist gene and coronary in-stent restenosis
    Zeynab Nickhah Klashami
    Atoosa Mostafavi
    Majid Gholamzadeh Roudbordeh
    Ali Abbasi
    Pirooz Ebrahimi
    Mojgan Asadi
    Mahsa M. Amoli
    Molecular Biology Reports, 2023, 50 : 8575 - 8587
  • [25] Interleukin-1 Receptor Antagonist: A Sensitive Marker of Instability in Patients with Coronary Artery Disease
    Giuseppe Patti
    Andrea D'Ambrosio
    Aldo Dobrina
    Giordano Dicuonzo
    Carlo Giansante
    Nicola Fiotti
    Antonio Abbate
    Gianfranco Guarnieri
    Germano Di Sciascio
    Journal of Thrombosis and Thrombolysis, 2002, 14 : 139 - 143
  • [26] Interleukin-1 receptor antagonist: A sensitive marker of instability in patients with coronary artery disease
    Patti, G
    D'Ambrosio, A
    Dobrina, A
    Dicuonzo, G
    Giansante, C
    Fiotti, N
    Abbate, A
    Guarnieri, G
    Di Sciascio, G
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2002, 14 (02) : 139 - 143
  • [27] Prognostic impact of Interleukin-1 receptor antagonist in patients with documented coronary artery disease
    Schofer, Niklas
    Ludwig, Sebastian
    Ruebsamen, Nicole
    Schnabel, Renate
    Lackner, Karl J.
    Ruprecht, Hans J.
    Bickel, Christoph
    Landmesser, Ulf
    Blankenberg, Stefan
    Zeller, Tanja
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 257 : 24 - 29
  • [28] Interleukin-1β and Interleukin-1 receptor antagonist gene polymorphism in pediatric patients with Helicobacter pylori-associated chronic gastritis
    Barakat, Sana Hosny
    Meheissen, Marwa Ahmed
    El-Gendi, Saba Mohamed
    Fouad, Ingy Ali
    Mahfouz, Aml Mohamed
    JOURNAL OF TROPICAL PEDIATRICS, 2021, 67 (03) : 1 - 10
  • [29] Interleukin-1 Receptor Antagonist Gene Polymorphism and Susceptibility to Ischemic Stroke
    Rezaii, Ali Akbar
    Hoseinipanah, Seyed Mohamad
    Hajilooi, Mehrdad
    Rafiei, Ali Reza
    Shikh, Nasrin
    Haidari, Mehran
    IMMUNOLOGICAL INVESTIGATIONS, 2009, 38 (3-4) : 220 - 230
  • [30] Interleukin-1 receptor antagonist gene polymorphism and multifetal pregnancy outcome
    Kalish, RB
    Vardhana, S
    Gupta, M
    Chasen, ST
    Perni, SC
    Witkin, SS
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (04) : 911 - 914